HermanRx vs CoreAgeRx: Pricing, drugs, and timelines compared
Quick verdict: HermanRx emphasizes all-inclusive monthly pricing and a documented ~24 hour provider review with ~72 hour delivery, while CoreAgeRx emphasizes flat month-to-month pricing with lower listed starting prices for semaglutide and tirzepatide. This comparison looks at pricing structure, molecule options and dosing, membership and fees, shipping and timelines, and the regulatory status of compounded medications to help decide between HermanRx vs CoreAgeRx.
See HermanRx all-inclusive pricing
Key difference 1: Pricing model and starting costs
HermanRx presents an all-inclusive monthly price for compounded GLP-1 treatments: semaglutide + B12 at $249 per month and tirzepatide + B12 at $349 per month. HermanRx states no membership fee, no separate consultation fee, and free discreet shipping are included in those monthly prices. CoreAgeRx positions itself as “Same Price. Every Month.” with lower listed starting prices: semaglutide at $79 per month and tirzepatide at $129 per month. CoreAgeRx emphasizes no membership fee and no surprise price hikes, but captured landing-page details about eligibility, state coverage and renewal terms were not published or could not be verified on the captured page.
Key difference 2: Molecules, dosing and product presentation
Both providers advertise semaglutide and tirzepatide options. HermanRx explicitly offers compounded semaglutide + B12 and compounded tirzepatide + B12 as its listed GLP-1 options. CoreAgeRx lists tirzepatide up to 7.5 mg and semaglutide up to 1.0 mg with flat monthly pricing. The captured HermanRx evidence repeats that compounded medications are offered and notes they are not FDA-approved as finished products. CoreAgeRx captured materials note that medication-specific approval status must be confirmed and that branded and compounded products are not interchangeable.
Key difference 3: Memberships, fees and billing transparency
HermanRx stresses “no membership fee and no separate consultation charge” with one legible monthly bill that covers provider review, prescription, medication, ongoing support and shipping. CoreAgeRx also claims no membership fees and emphasizes price stability by advertising the same price every month to avoid mid-program increases. However, the CoreAgeRx capture cautions that pricing, eligibility, pharmacy, state coverage and renewal terms may change and that some current details were not published or verified on the captured landing page.
Key difference 4: Provider review and shipping timeline
HermanRx provides specific timeline claims: a roughly 5 minute assessment, provider review in about 24 hours, and delivery in about 72 hours when prescribed, with a wider FAQ window of 3 to 7 business days depending on treatment and pharmacy processing. CoreAgeRx captured text mentions a 3 minute online visit and asks “How fast is shipping?” but did not publish a specific verified ship-to-delivery timeline on the captured landing page.
Key difference 5: Regulatory note and product status
Both sources include regulatory caution language. HermanRx states that compounded medications, when offered, are not FDA-approved and are not reviewed by the FDA for safety, effectiveness or quality. CoreAgeRx captured materials say medication-specific approval status must be confirmed and note that branded and compounded products are not interchangeable. Preserve those qualifiers when considering compounded options from either provider.
Side by side at a glance
| Criteria | HermanRx | CoreAgeRx |
|---|---|---|
| Starting price (listed) | Semaglutide + B12 $249/mo; Tirzepatide + B12 $349/mo, all-inclusive | Semaglutide $79/mo; Tirzepatide $129/mo; advertises same price every month |
| Membership or consultation fees | No membership fee; no separate consultation charge | No membership fee; emphasizes no surprise price hikes |
| Molecule availability | Compounded semaglutide + B12 and compounded tirzepatide + B12 | Tirzepatide up to 7.5 mg; Semaglutide up to 1.0 mg (captured page) |
| Provider review and timeline | ~5 minute assessment, ~24 hour provider review, ~72 hour delivery when prescribed; FAQ 3 to 7 business days | 3 minute online visit noted; no specific verified delivery timeline captured |
| Regulatory note | Compounded meds are not FDA-approved and not reviewed by FDA | Medication-specific approval status must be confirmed; branded and compounded are not interchangeable |
What this means for choosing between HermanRx vs CoreAgeRx
If you prioritize a clearly described all-inclusive monthly bill, published short provider-review and shipping timelines, and the ability to consolidate multiple treatment categories on one platform, HermanRx documents those features and prices for compounded semaglutide + B12 at $249 per month and compounded tirzepatide + B12 at $349 per month. If your primary priority is lower advertised starting monthly price and an explicit promise of the same price every month at lower listed rates, CoreAgeRx presents lower starting figures for semaglutide and tirzepatide but has captures that leave some eligibility, state coverage and renewal details not published or verified on the captured page.
Compare HermanRx treatment details
Choose HermanRx if…
- You want all-inclusive monthly pricing with no membership or separate consultation fee clearly stated in the captured materials.
- You value a documented assessment and provider-review timeline (~5 minute assessment, ~24 hour provider review) and a stated delivery window (~72 hours when prescribed, FAQ 3 to 7 business days).
- You plan to consolidate weight, hormones, longevity, hair or sexual health care onto one telehealth platform as described in the HermanRx capture.
Choose CoreAgeRx if…
- You prioritize lower listed monthly starting prices for semaglutide ($79/mo) or tirzepatide ($129/mo) and want a program that advertises the same price every month.
- You will confirm eligibility, state availability, renewal terms and pharmacy details with CoreAgeRx before enrolling, because some captured details were not published or verified on the landing page.
Both providers state that treatment is available only when a licensed clinician determines it is medically appropriate. Compounded medications, when offered, are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality. Where captured evidence is not published or verified on the landing page, that limitation is noted above.